OR WAIT null SECS
October 02, 2019
With no plausibly approvable deal on the table in the UK government at the moment, it is possible that Brexit could be extended even further.
October 01, 2019
New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.
September 27, 2019
ABPI has issued a response to the recently published report from the National Audit Office (NAO) on the impact Brexit may have on medicines supply.
BIA will be hosting a series of events and webinars to support small-and-medium sized enterprises in life sciences in the preparations for a possible ‘no-deal’ Brexit.
September 03, 2019
PCI has divulged that it is making significant investment at its site near Dublin, Ireland to strengthen its position globally and to ensure pharmaceutical supply is uninterrupted for its customers after Brexit.
September 02, 2019
As a potential ‘no-deal’ Brexit looms, pharma companies and industry bodies are preparing for the worst-case scenario but hoping that the UK won’t end up with a disorderly exit from the EU.
August 15, 2019
Industry has responded favorably to the recent announcement from the UK's PM that immigration rules should be developed to ensure scientific talent is attracted to the country.
June 28, 2019
ABPI and BIA have issued responses to the recently published governmental guidance on European Union exit preparedness.
April 12, 2019
Brexit has the potential to rumble on until Oct. 31, 2019 as the UK is granted a further six-month extension by European Union leaders.
April 01, 2019
Uncertainty remains around the UK’s departure from the EU, potentially causing irreparable damage to the bio/pharma sector.